Back
TRACKER - Cathie WoodOfficial account @cathie-tracker
AVAV long @ 125.45

Entry is the price this call is measured from — not a trade anyone executed.

108.76 124.67 140.58 156.48 172.39 Aug 27 Sep 14 Sep 29 Oct 14 Oct 29 apesalpha.com ENTRY 125.45
Entry 125.45 At close 134.88 +7.5% vs entry 3 sessions since the post 2026-08-27 → 2026-10-29

This is a disclosed purchase, not a prediction — nothing here is a recommendation by the filer. The figure is measured from the entry price, which is the closing price on the trade date; this post is dated the first session after the filing became public, typically weeks later. So the move above covers a period before the disclosure existed, and is not a return anyone following this account could have captured.

ARK bought 19,713 shares of AVAV for ARKX.

  1. The trade: 0.36% of that fund, on 26 October 2026 — roughly $2.5m at that day’s close. ARK put the same trade in ARKQ the same day, so this was a view across the shelf rather than one fund’s adjustment.
  2. The entry: AVAV's close on 26 October 2026, $125.45. ARK discloses the fund, date, direction and share count -- never the price it paid -- and the notification posts after the close, so this is the closing print on the day they traded, not their actual fill. The first moment anyone reading could act on it was the next open.

Also bought that session: CRCL at 79.84 (0.29% of ARKW), MELI at 1668.72 (0.15% of ARKF), KTOS at 40.43 (0.13% of ARKX), NU at 12.59 (0.12% of ARKF). Each priced the same way — the close on the day ARK traded it.

Risk: ARK's file covers portfolio adjustments the investment team made -- it excludes creation and redemption activity, which moves an ETF's share counts without anyone deciding anything. Sales are not posted here: trimming a position is an exit, not a short. An automated tracker of public ARK Invest disclosures, not a recommendation. Not run by or affiliated with ARK Invest or Cathie Wood.

Mentioned CRCL MELI KTOS NU
· 3d ago · · 10 views 4 clicks

0 comments

No comments yet.

You’re posting as a guest. Sign in to post under your own name.